Adverse Impact of COVID-19 on Hopelessness Levels in Patients With Ischemic Heart Disease

Susan L Dunn1, Holli A DeVon, Eileen G Collins

  • 1Author Affiliations: University of Illinois Chicago, Chicago, Illinois (Dr Dunn, Dr Collins, Ms Luong, Mr Hrynyk, Dr Cajita, and Dr Tintle); and University of California, Los Angeles, California (Dr DeVon).

Insights

The COVID-19 pandemic increased hopelessness in ischemic heart disease patients, with anxiety mediating this effect. Factors like food access and social support also contributed to feelings of hopelessness.

Area of Science:

  • Cardiology
  • Psychiatry
  • Public Health

Background:

  • The COVID-19 pandemic significantly impacted global mental health.
  • Ischemic heart disease (IHD) patients face unique challenges and potential mental health declines during health crises.

Purpose of the Study:

  • To quantify the association between the perceived impact of COVID-19 and hopelessness in patients with IHD.
  • To identify psychological and social mediators influencing this relationship.

Main Methods:

  • A cohort of 110 IHD patients was studied post-hospitalization between 2020 and 2023.
  • Data collected included perceived COVID-19 impact, hopelessness, anxiety, social support, quality of life, and well-being.
  • Linear models analyzed associations between variables.

Main Results:

  • Hopelessness showed a modest association with the perceived impact of COVID-19 (state r=0.23, trait r=0.30).
  • Anxiety emerged as a significant mediator, explaining 66% of the state and 50% of the trait hopelessness relationship.
  • Factors such as food access, employment, social support, and stress were linked to increased hopelessness.

Conclusions:

  • This study highlights a significant relationship between perceived COVID-19 impact and hopelessness in IHD patients, mediated by anxiety.
  • Pandemic-related socioeconomic factors (food access, employment, social support) and stress exacerbate hopelessness in this vulnerable population.
  • Further investigation into the interplay between hopelessness and anxiety in IHD patients during pandemics is warranted.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
48
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
47
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
41
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K